참고문헌
- Saho U, Haruka F, Chie H, Masatoshi N, Mutsuhiko M: M class I-mediated exogenous antigen presentation by exosom secreted from immature and mature bone marrow deriv dendritic cells. Immunology Letters 89;125-131, 2003 https://doi.org/10.1016/S0165-2478(03)00128-7
- Inaba K, lnaba M, Romani N, Ava H, Dezuchi M, Ikeh S, Muramatsu S, Steinman RM: Generation of large numb of dendritic cells from mouse bone marrow cultures supp mented with granulocyte/macrophage colony-stimulating tor. J Exp Med 176;1693-1702, 1992 https://doi.org/10.1084/jem.176.6.1693
- Shen Z, Reznikoff G, Dranoff G, Rock KL: Cloned dendr cells can present exogenous antigens on both MHC clas and class II molecules. J Immunol 15;2723-2730, 1997
- Zitvozel L, Reanault A, Lozier A, Wolfers J, Flament C, T za D, Ricciardi-Castagnoli P, Raposo G, Arnizorena S: Era cation of established murine tumors using a novel cell-f vaccine: dendritic cell-derived exosomes. Nat Med 4;594-600 1998 https://doi.org/10.1038/nm0598-594
- Avigan DD: Dendritic cells: development, function and tential use for cancer immunotherapy. Blood Reviews 13;51-64, 1999 https://doi.org/10.1016/S0268-960X(99)90023-1
- Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, LD Jr: Peptide-pulsed dendritic cells induce antizen-speci CTL-mediated protective tumor immunity. J Exp Med 183;283-287, 1996 https://doi.org/10.1084/jem.183.1.283
- Shurin MR: Dendritic cells presenting tumor antigen. Can Immunol Immunother 43;158-164, 1996 https://doi.org/10.1007/s002620050317
- Moron G, Dadaclio G, Leclerc C: New tools for antig delivery to the MHC class I pathway. Trends Immunol 25;92-97, 2004 https://doi.org/10.1016/j.it.2003.11.008
- Hart DN: Dendritic cells: unique leukocyte populations, w control the primary immune response. Blood 90;3245-3287, 1997
- Fernandez NC, Lozier A, Flament C, Ricciardi-Castagno Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovskv Zirvogel L: Dendritic cells directly trigger NK cell functio Cross-talk relevant in innate anti-tumor immune response vivo. Nature Medicine 5;405-411, 1999 https://doi.org/10.1038/7403
- Fields RC, Shimizu K, Mule JJ: Murine dendritic cells pu with whole tumor lysates mediate potent antitumor imm responses in vitro and in vivo. Proc Natl Acad Sci 95;9482-9487, 1998
- Inaba K. Young JW, Steinman RM: Direct activation of CD cytotoxic T lymphocytes by dendritic cells. J Exp Med 166; 182-194, 1987 https://doi.org/10.1084/jem.166.1.182
- Muller L, Provenzani C. Faul C. Pawelec G: Recognition chronic myelogenous leukemia cells by autologous T lymp cytes primed in vitro against the patient's dendritic cells. Br J Hematol 112;740-748, 2001 https://doi.org/10.1046/j.1365-2141.2001.02596.x
- Jean FF, Daniel GK, Margareta L, Catherine S, Timothy Nina B, Marie L: Characterization of the MHC class I cro presentation pathway for cell-associated antigens by hum dendritic cells. Blood 102;4448-4455, 2003 https://doi.org/10.1182/blood-2003-06-1801
- Palucka K, Bancherau J: Dendritic cells: a link between inn and adaptive immunity. J Clin Immunol 19;12-25, 1999 https://doi.org/10.1023/A:1020558317162
- Flamand V, Sornasse T, Thielemans K, Demanet C, Bak M, Bazin H, Tielemans F, Leo O, Urbain J. Moser M: Mu dendritic cells pulsed in vitro with tumor antigen induce mor resistance in vivo. Eur J Immunol 24;605-610, 1994 https://doi.org/10.1002/eji.1830240317
- Fong L, Engleman EG: Dendritic cells in cancer immunot rapy. Annul Rev Immunol 18;245-273, 2000 https://doi.org/10.1146/annurev.immunol.18.1.245
- Gong J. Chen D, Kashiwaba M, Kufe D: Induction of anti mor activity by immunization with fusions of dendritic carcinoma cells. Nat Med 3:558-561, 1997 https://doi.org/10.1038/nm0597-558
- Gong J, Avizan D, Chen D, Wu Z, Koido S, Kashiwaba Kufe D: Activation of antitumor cytotoxic T lymphocyte fusions of human dendritic cells and breast carcinoma ce Proc Natl Acad Sci 97;2715-2718, 2000
- Inaba K. Metlay JP, Crowley MT, Steinman RM: Dendritic pulsed with protein antigens in vitro can prime antigen-spec MHGrestricted T cells in situ. J Exp Med 172;631-640, 1990 https://doi.org/10.1084/jem.172.2.631
- Mayordomo JI, Zorina T, Storkus WJ. Zitvogel L, Cell C. Falo LD, Melief CJ. Ildstad ST, Kast WM, Deleo A: Bo marrow-derived dendritic cells pulsed with synthetic tum peotides elicit protective and therapeutic antitumour imm nity. Nat Med 1:1297-1302, 1995 https://doi.org/10.1038/nm1295-1297
- Lee JK, Lee MK, Yun YP: Acemannan purified from A vera induces phenotypic and functional maturation of im ture dendritic cells. Int Immunopharmacol 1:1275-1284, 2001 https://doi.org/10.1016/S1567-5769(01)00052-2
- Lee YR, Yang IH, Lee YH, Im SA, Song S, Li H, Han Kim K, Eo SK, Lee CK: Cyclosporin A and tacrolimus, not rapamycin, inhibit MHC-restricted antigen presenta pathways in dendritic cells. Blood 105;3951-3955, 2005 https://doi.org/10.1182/blood-2004-10-3927
- Han S, Sung KH, Yim D, Lee S, Cho K, Lee CK, Ha N Kim K: Activation of murine macrophage cell line RA 264.7 by Korean Propolis. Arch Pharm Res 25:895-902, 2002 https://doi.org/10.1007/BF02977011
- Ivanovsca ND, Dimov VD, Pavlova S, Bankova VS, Pop SS, Immunomodulatorv action of propolis. VI. Anticom mentary activity of a water-soluble derivative. J Ethnophar macology 47;135-143, 1995 https://doi.org/10.1016/0378-8741(95)01273-G
- Harborne JB, Williams CA: Advances in flavonoid resea since 1992. Phytochemistry. 55;481-504, 2000 https://doi.org/10.1016/S0031-9422(00)00235-1
- Shen Z, Reznikoff G, Dranoff G, Rock KL: Cloned dendr cells can present exogenous antigens on both MHC clas and class II molecules. J Immunol 158;2723-2730, 1977
- Karttunen J, Sanderson S, Shastri N: Detection of rare an gen-presenting cells by the lacZ T-cell activation assay su gests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sc 89;6020-6024, 1992
- Harding CV, Collins D, Kanagawa O, Unanue ER: Lipo me-encapsulated antigens engender lysosomal processing f class II MHC presentation and cvtosolic processing for cl I presentation. J Immunol 147;2860-2863, 1991
- Porgador A, Yewdell JW, Deng Y, Bennink JR. Germain Localization, quantitation, and in situ detection of spec peptide-MHC class I complexes using monoclonal antibody. Immunity 6;715-726, 1997 https://doi.org/10.1016/S1074-7613(00)80447-1
- Yeh KY, McAdam AJ, Pulaski BA, Shastri N, Prelinzer Lord EM: IL-3 enhances both presentation of exogeno particulate antigen in association with class I major histoco patibility antigen and generation of primary tumor-spec cytolytic T lymphocytes. J Immunol 160;5773-5780, 1998
- Larsson M, Fonteneau JF, Bhardwaj N: Dendritic cells surrect antigens from dead cells. Trends Immunol 22;14 148, 2001
- Yewdell JW, Norbury CC, Bennink JR: Mechanisms of ogenous antigen presentation by MHC class I molecules vitro and in vivo: implications for generating CD8+ T responses to infectious agents, tumors, transplants, and v cines. Adv Immunol 73;1-77, 1999 https://doi.org/10.1016/S0065-2776(08)60785-3
- Steinman RM, Inaba K, Turley S, Pierre P, Mellman I: tigen capture, processing, and presentation by dendritic ce recent cell biological studies. Hum Immunol 60;562-5 1999 https://doi.org/10.1016/S0198-8859(99)00030-0